文献詳細
文献概要
連載 今月の話題
常染色体劣性網膜色素変性の新たな展望
著者: 堀田喜裕1
所属機関: 1浜松医科大学眼科学講座
ページ範囲:P.1545 - P.1550
文献購入ページに移動 網膜色素変性は遺伝的異質性の強い疾患であることが知られており,すでに60を超える原因遺伝子が報告されている。最近の研究によって,EYS 遺伝子異常が,わが国の常染色体劣性網膜色素変性の2〜3割を占めることが明らかにされた。特にEYS 遺伝子のc.4957_4958insA変異(insA変異)は極端に多く,日本人の約200人に1人が片方のアレルにこの変異をもっている。本発見による今後の可能性について考える。
参考文献
1)Watson JD, Crick FH:Molecular structure of nucleic acids:a structure for deoxyribose nucleic acid. Nature 171:737-738, 1953
2)Sanger F, Nicklen S, Coulson AR:DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463-5467, 1977
3)村上 晶・藤巻拓郎・藤木慶子・他:眼科遺伝子診療をめざした遺伝情報解析.日眼会誌 118:283-297,2014
4)Dryja TP, McGee TL, Reichel E et al:A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 343:364-366, 1990
gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One 7:e31036, 2012
genes in Japanese patients with autosomal recessive retinitis pigmentosa. Invest Ophtalmol Vis Sci 53:1033-1040, 2012
7)堀田喜裕・塩野 貴・早川むつ子・他:日本人の常染色体優性網膜色素変性患者のロドプシン遺伝子の分子生物学的検討.日眼会誌 96:237-242,1992
8)玉井 信:網膜色素変性と加齢黄斑変性:病態研究と治療研究の進展.日眼会誌 108:750-769,2004
9)Jin ZB, Mandai M, Yokota T et al:Identifying pathogenic genetic background of simplex or multiplex retinitis pigmentosa patients:a large scale mutation screening study. J Med Genet 45:465-472, 2008
spacemaker, is mutated in autosomal recessive retinitis pigmentosa. Nat Genet 40:1285-1287, 2008
eyes shut/spacemaker that is mutated in patients with retinitis pigmentosa. Am J Hum Genet 83:594-603, 2008
is a major gene for rod-cone dystrophies in France. Hum Mutat 31:E1406-E1435, 2010
)causing autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 51:4266-4272, 2010
gene account for approximately 5% of autosomal recessive retinitis pigmentosa and cause a fairly homogeneous phenotype. Ophthalmology 117:2026-2033, 2010
in Spanish patients with autosomal recessive retinitis pigmentosa. Hum Mutat 31:E1772-E1800, 2010
16)Dryja TP, Hahn LB, Cowley GS et al:Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A 88:9370-9874, 1991
17)Fujiki K, Hotta Y, Hayakawa M et al:Point mutations of rhodopsin gene found in Japanese families with autosomal dominant retinitis pigmentosa(ADRP). Jpn J Hum Genet 37:125-132, 1992
18)Fu Q, Wang F, Wang H et al:Next-generation sequencing-based molecular diagnosis of a Chinese patient cohort with autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 54:4158-4166, 2013
19)Jinda W, Taylor TD, Suzuki Y et al:Whole exome sequencing in Thai patients with retinitis pigmentosa reveals novel mutations in six genes. Invest Ophthalmol Vis Sci 55:2259-2268, 2014
gene. Ophthalmic Genet 35:25-34, 2014
alleles in an outbred population. Hum Mol Genet 19:3693-3701, 2010
遺伝子変異とその臨床像.臨眼 67:275-279,2013
gene. Doc Ophthalmol 128:211-217, 2014
24)Berson EL, Rosner B, Sandberg MA et al:Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment:subgroup analyses. Arch Ophthalmol 122:1306-1314, 2004
. Seattle:University of Washington, Seattle, 2013
26)Rotenstreich Y, Belkin M, Sadetzki S et al:Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa:a randomized crossover trial. JAMA Ophthalmol 131:985-992, 2013
27)大黒 浩:網膜色素変性に対するあたらしい薬物療法の可能性.日眼会誌 112:7-21,2008
28)Clemson CM, Tzekov R, Krebs M et al:Therapeutic potential of valproic acid for retinitis pigmentosa. Br J Ophthalmol 95:89-93, 2011
-mediated retinal dystrophies following vitamin A supplementation. Invest Ophthalmol Vis Sci 49:3821-3829, 2008
30)Emerich DF, Thanos CG:NT-501:an ophthalmic implant of polymer-encapsulated ciliary neurotrophic factor-producing cells. Curr Opin Mol Ther 10:506-515, 2008
31)Michaud J, Thompson GN, Brody LC et al:Pyridoxine-responsive gyrate atrophy of the choroid and retina:clinical and biochemical correlates of the mutation A226V. Am J Hum Genet 56:616-622, 1995
. Am J Hum Genet 44:344-352, 1989
33)Jin ZB, Okamoto S, Osakada F et al:Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One 6:e17084, 2011
掲載誌情報